 |
|
| ANTIDIABETIC AGENTS: RECENT ADVANCES IN THEIR MOLECULAR AND CLINICAL PHARMACOLOGY, 27
| |
| | |
|
|
To order this title, and for more information, click here
Bernard Testa, University Hospital Centre, Lausanne, Switzerland
Urs Meyer, Biocentre, University of Basel, Switzerland
Description
Volume 27, the first thematic volume in the Series, provides an overview of present knowledge with regard to the pharmacological and clinical
aspects of antidiabetic drugs. It aims to stimulate further consideration of possible concepts in the development of new antidiabetic
drugs.
Audience
Pharmacologists, medicinal chemists, and toxicologists.
Contents
Introduction.
Regulation of Glucose Homeostasis.
Clinical Aspects of Diabetes Mellitus.
Mechanisms of Insulin Action.
Therapeutic Use
of Insulin.
The Secretory Machinery of Insulin Release.
Compounds Acting on Insulin Secretion: Sulphonylureas.
Compounds Acting on Glucose
Uptake: Biguanides.
Compounds Acting on Glucose Absorption.
Aldose Reductase Inhibitors as New Antidiabetic Drugs.
Conclusions.
References.
Cumulative Index of Authors.
Cumulative Index of Titles.
| Bibliographic details |
Hardbound, 231 pages, publication date: MAY-1996
ISBN-13: 978-0-12-013327-7
ISBN-10: 0-12-013327-X
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company